Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic to Lay Off 80 as Part of Genomics Division Restructuring

NEW YORK (GenomeWeb News) — Gene Logic said today that it will lay off approximately 80 employees in its genomics division by Oct. 5 as it restructures the unit.
 
The company announced the restructuring in June when it said the genomics division revenues would be "significantly lower" than anticipated for both the second quarter and the full year of 2006. Gene Logic withdrew its financial guidance for 2006 and 2007 as a result.
 
Today, Gene Logic said the staff reductions will cut its annual salary and fringe benefits costs by approximately $8 million. The company said it also expects “additional savings in certain non-employee costs. ..."
 
Following the lay-offs, retained employees will “support existing products and services and ensure ongoing service levels are effectively maintained for current and prospective customers," Gene Logic said.
 
The company added that “affected employees will be given severance and outplacement assistance costing approximately $1.5 million.”
 
The lay-offs will not affect Gene Logic's preclinical and drug-repositioning divisions, the company said.
 
The company is scheduled to report its second-quarter results on Friday.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.